絞り込み

16644

広告

「vildagliptin」の検索結果

1053件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Testosterone Replacement Therapy and the Risk of Hypoglycemia.

Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study.

DPP8 is a novel therapeutic target for multiple myeloma.

Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycemia and hormonal responses in metformin-treated type 2 diabetes.

Insights Into GLP-1 and GIP Actions Emerging From Vildagliptin Mechanism Studies in Man.

Protective effect of dipeptidyl peptidase-4 inhibitors in testicular torsion/detorsion in rats: a possible role of HIF-1α and nitric oxide.

Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice.

Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial Dysfunction.

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.

Protective effect of vildagliptin on myocardial injury in septic rats by regulating TLR-4/NF-κB pathway.

Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: a nationwide cohort study.

Role of endogenous glucagon-like peptide-1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetes.

Safety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin.

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo.

Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents.

Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators.

Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-][1,4]oxazine derivatives as potent GPR 119 agonists.

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors. A case series and analysis of cases reported in the Spanish pharmacovigilance database.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります